FDA Approved: PRADAXA — Original Application (Boehringer Ingelheim Pharmaceuticals, Inc.)

View source ↗

Summary

FDA approved the original application for Pradaxa (dabigatran etexilate) from Boehringer Ingelheim, marking the initial NDA approval for this oral anticoagulant…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nonvalvular Atrial Fibrillation

Drugs mentioned

• Pradaxa (dabigatran etexilate)

Snippet

ORIG AP for PRADAXA (DABIGATRAN ETEXILATE)